Vestal Point Capital, LP Relmada Therapeutics, Inc. Transaction History
Vestal Point Capital, LP
- $1.34 Trillion
- Q2 2024
A detailed history of Vestal Point Capital, LP transactions in Relmada Therapeutics, Inc. stock. As of the latest transaction made, Vestal Point Capital, LP holds 1,200,000 shares of RLMD stock, worth $4.19 Million. This represents 0.27% of its overall portfolio holdings.
Number of Shares
1,200,000
Previous 1,200,000
-0.0%
Holding current value
$4.19 Million
Previous $5.58 Billion
35.48%
% of portfolio
0.27%
Previous 0.46%
Shares
2 transactions
Others Institutions Holding RLMD
# of Institutions
86Shares Held
13.5MCall Options Held
99KPut Options Held
28.2K-
Vanguard Group Inc Valley Forge, PA1.26MShares$4.39 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT1.23MShares$4.31 Million0.12% of portfolio
-
Acadian Asset Management LLC Boston, MA1.19MShares$4.16 Million0.01% of portfolio
-
Franklin Resources Inc San Mateo, CA1.01MShares$3.53 Million0.0% of portfolio
-
Parsons Capital Management Inc1MShares$3.5 Million0.21% of portfolio
About RELMADA THERAPEUTICS, INC.
- Ticker RLMD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,608,500
- Market Cap $99.8M
- Description
- Relmada Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing various products for the treatment of central nervous system (CNS) diseases and other disorders. Its lead product candidate is Esmethadone (d-methadone, dextromethadone, and REL-1017), a new chemical entity and N-methyl-D-aspartate receptor antagonist that ...